Boniver R, Arendt C
Oto-rhino-laryngologie, Verviers, Belgique.
Acta Otorhinolaryngol Belg. 1989;43(1):75-81.
Thirty patients suffering from perennial allergic rhinitis took part in a cross-over, double-blind study during which they were treated for 3 two-week periods with either 10 mg cetirizine nocte or 60 mg terfenadine given morning and evening, or with a placebo. Both the active products were found to significantly improve the symptoms when compared to placebo (p less than or equal to 0.001). Cetirizine helped to reduce the symptoms of a blocked nose to a significantly greater extent than terfenadine (p less than or equal to 0.05). A significantly larger number of patients (p less than or equal to 0.05) preferred cetirizine (17/30) to terfenadine (6/30). Four patients taking cetirizine, and six of those taking terfenadine, reported a mild sedative effect.
30名常年性变应性鼻炎患者参与了一项交叉双盲研究,在此期间,他们接受了为期3个两周疗程的治疗,治疗方式为每晚服用10毫克西替利嗪,或早晚各服用60毫克特非那定,或服用安慰剂。与安慰剂相比,两种活性药物均能显著改善症状(p≤0.001)。与特非那定相比,西替利嗪在更大程度上有助于减轻鼻塞症状(p≤0.05)。明显更多的患者(p≤0.05)更喜欢西替利嗪(17/30)而非特非那定(6/30)。4名服用西替利嗪的患者和6名服用特非那定的患者报告有轻微的镇静作用。